NZ593811A - Glucagon analogues - Google Patents

Glucagon analogues

Info

Publication number
NZ593811A
NZ593811A NZ593811A NZ59381108A NZ593811A NZ 593811 A NZ593811 A NZ 593811A NZ 593811 A NZ593811 A NZ 593811A NZ 59381108 A NZ59381108 A NZ 59381108A NZ 593811 A NZ593811 A NZ 593811A
Authority
NZ
New Zealand
Prior art keywords
asp
ala
ser
tyr
thr
Prior art date
Application number
NZ593811A
Inventor
Eddi Meier
Ditte Riber
Marie Skovgaard
Bjarne Due Larsen
Jens Rosengren Daugaard
Original Assignee
Zealand Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zealand Pharma As filed Critical Zealand Pharma As
Priority to NZ593811A priority Critical patent/NZ593811A/en
Priority claimed from PCT/GB2008/004130 external-priority patent/WO2010070252A1/en
Publication of NZ593811A publication Critical patent/NZ593811A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

593811 Provided is a compound having the formula R1-X-Z-R2, wherein R1 is hydrogen, C1-4 alkyl, acetyl, formyl, benzoyl or trifluoroacetyl; X is a peptide which has the formula His-Ser -Gln-Gly-Thr-Phe-Thr -Ser-Asp-Tyr -Ser -Lys-Tyr -Leu-Asp-Arg-Ala-Arg-Ala-Asp-Asp-Phe-ValAla-Trp-Leu-Lys-Glu-Ala, wherein 1-4 specified amino acids can be modified, and Z is absent or a sequence of 1-20 amino acid units selected from the group consisting of Ala, Leu, Ser, Thr, Tyr, Cys, Glu, Lys, Arg, Dbu, Dpr and Orn. The compound can be used to treat or prevent obesity and associated diseases.
NZ593811A 2008-12-15 2008-12-15 Glucagon analogues NZ593811A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ593811A NZ593811A (en) 2008-12-15 2008-12-15 Glucagon analogues

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/GB2008/004130 WO2010070252A1 (en) 2008-12-15 2008-12-15 Glucagon analogues
NZ593811A NZ593811A (en) 2008-12-15 2008-12-15 Glucagon analogues

Publications (1)

Publication Number Publication Date
NZ593811A true NZ593811A (en) 2013-03-28

Family

ID=48575091

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ593811A NZ593811A (en) 2008-12-15 2008-12-15 Glucagon analogues

Country Status (1)

Country Link
NZ (1) NZ593811A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10479819B2 (en) 2014-09-23 2019-11-19 Xianxing JIANG Oxyntomodulin analogue

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10479819B2 (en) 2014-09-23 2019-11-19 Xianxing JIANG Oxyntomodulin analogue

Similar Documents

Publication Publication Date Title
NZ597554A (en) Selective glucagon-like-peptide-2 (glp-2) analogues
PE20130326A1 (en) GLUCAGON ANALOGS
PH12014500922A1 (en) Insulinotropic peptide derivative wherein its n-terminal amino acid is modified
MX2008009493A (en) Novel peptide and use thereof.
NZ603811A (en) Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
NZ599161A (en) Method for activation of helper t cell and composition for use in the method
EP2213680B1 (en) Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
IN2014CN02050A (en)
RS53505B1 (en) Oxyntomodulin peptide analogue
WO2011038900A3 (en) Peptide analogues of glucagon for diabetes therapy
PE20120358A1 (en) FGF21 MUTANTS AND USES OF THEM
EA019203B9 (en) Glucagon/glp-1 receptor co-agonists
MX2009006564A (en) Glucagon analogs exhibiting enhanced solubility in physiological ph buffers.
NZ592510A (en) HLA-A*1101-restricted WTI peptide and pharmaceutical composition comprising the same
WO2011080102A3 (en) Glp-1 analogues and derivatives
AU2003264514A8 (en) Wt1 substitution peptides
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
RU2015103816A (en) CELLING PEPTIDES IN THE CELL, THE TARGET OF WHICH IS THE eIF4E
NZ756128A (en) Novel peptides and analogs for use in the treatment of oral mucositis
WO2008047370A3 (en) Compositions and methods for inducing angiogenesis
HRP20240371T1 (en) Acylated oxyntomodulin peptide analog
NZ593811A (en) Glucagon analogues
NZ597777A (en) Motilin-like peptide compound having transmucosal absorbability imparted thereto
HK1131162A1 (en) Cytokine derivatives
AU2016232361B2 (en) Cyclic galanin-analogs and uses thereof

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 15 DEC 2015 BY HENRY HUGHES

Effective date: 20130911

LAPS Patent lapsed